Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Wai Chun Bio-Technology Ltd. ( (HK:0660) ).
Wai Chun Bio-Technology Ltd. announced a delay in the dispatch of a circular concerning its proposed capital reorganization and alteration of terms for existing convertible bonds. The revised schedule indicates that the circular will be sent to shareholders by April 8, 2025, with key dates for shareholder meetings and voting set for late April. This delay may impact the company’s financial structuring and stakeholder engagement.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. It is listed on the Hong Kong Stock Exchange and is involved in capital reorganizations and financial transactions related to convertible bonds.
YTD Price Performance: 50.0%
Average Trading Volume: 187,062
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$18.01M
For detailed information about 0660 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue